| Novartis's Kymriah wins speedy reviews in U.S., Europe | | | ZURICH (Reuters) - Novartis has been granted fast-track reviews of its cell therapy Kymriah for blood cancers in the United States and Europe, the Swiss drugmaker said on Wednesday, as it seeks to expand the pool of patients eligible for the costly treatment. |
| |
| WHO recommends yellow fever shot to Sao Paulo visitors | | | BRASILIA (Reuters) - The World Health Organization said on Tuesday that the whole of Sao Paulo state, which includes Brazil's largest city, Sao Paulo, should be considered at risk for yellow fever and recommended foreign travelers get vaccinated before visiting. |
| |
| FDA to speed review of medical products for use by military | | | (Reuters) - The U.S. Food and Drug Administration and Department of Defense launched a program on Tuesday to speed the development and review of medical products needed by the military, such as freeze-dried plasma that could prevent wounded troops from bleeding to death. |
| |
| UK drugs regulator plays down Brexit disruption threat | | | LONDON (Reuters) - Britain's drugs regulator said on Tuesday it would work to minimise disruption caused by the country leaving the European Union as it tried to allay some of the worst fears of pharmaceutical companies. |
| |
| Childhood bullying linked to suicide risk for teens | | | (Reuters Health) - Adolescents who experienced severe bullying by their peers earlier in childhood may be more likely to suffer from depression, anxiety and suicidal thoughts than teens who weren’t routinely victimized by other kids, a Canadian study suggests. |
| |
| U.S. healthcare uninsured rises most in near decade: Gallup | | | WASHINGTON (Reuters) - The number of Americans without healthcare insurance rose by 3.2 million people between 2016 and 2017, or 1.3 percentage points to 12.2 percent, according to a Gallup poll released on Tuesday, the biggest jump in the uninsured rate in nearly a decade. |
| |
| | |
